multiplex panels Search Results


multiplex enzyme linked immunosorbent assay elisa kit  (Boster Bio)
94
Boster Bio multiplex enzyme linked immunosorbent assay elisa kit
Multiplex Enzyme Linked Immunosorbent Assay Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/Multiplex+ELISA+Kit+For+Human+Cytokine+Panel+2/pm36359864-101-24-37
Average 94 stars, based on 1 article reviews
multiplex enzyme linked immunosorbent assay elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier
multiplex elisa kit  (Boster Bio)
93
Boster Bio multiplex elisa kit
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Multiplex Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/Multiplex+ELISA+Kit+For+Mouse+Cytokine+Panel+2/pmc12006996-251-11-15
Average 93 stars, based on 1 article reviews
multiplex elisa kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
mouse cytokine panel 1  (Boster Bio)
93
Boster Bio mouse cytokine panel 1
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Mouse Cytokine Panel 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/Multiplex+ELISA+Kit+For+Mouse+Cytokine+Panel+1/pmc10787251-293-17-23
Average 93 stars, based on 1 article reviews
mouse cytokine panel 1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
human cytokine panel 1  (Boster Bio)
93
Boster Bio human cytokine panel 1
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Human Cytokine Panel 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/Multiplex+ELISA+Kit+For+Human+Cytokine+Panel+1/pm36359864-101-31-37
Average 93 stars, based on 1 article reviews
human cytokine panel 1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
multiplex molecular stool panel gastrointestinal pathogens  (BioFire Defense)
90
BioFire Defense multiplex molecular stool panel gastrointestinal pathogens
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Multiplex Molecular Stool Panel Gastrointestinal Pathogens, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/multiplex+molecular+stool+panel+gastrointestinal+pathogens/10__1128_slash_jcm__00677___19-16-19-21
Average 90 stars, based on 1 article reviews
multiplex molecular stool panel gastrointestinal pathogens - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
multiplexed immunoassay panels  (Meso Scale Diagnostics LLC)
90
Meso Scale Diagnostics LLC multiplexed immunoassay panels
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Multiplexed Immunoassay Panels, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/multiplexed+immunoassay+panels/10__1161_slash_circheartfailure__119__006414-36-6-8
Average 90 stars, based on 1 article reviews
multiplexed immunoassay panels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
amyloid beta magnetic bead panel - multiplex assay  (Merck KGaA)
90
Merck KGaA amyloid beta magnetic bead panel - multiplex assay
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Amyloid Beta Magnetic Bead Panel Multiplex Assay, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/amyloid+beta+magnetic+bead+panel+++multiplex+assay/pmc06694377-129-16-24
Average 90 stars, based on 1 article reviews
amyloid beta magnetic bead panel - multiplex assay - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
multiplexed immunoassay array human discoverymap 175+ v1.0  (Myriad RBM)
90
Myriad RBM multiplexed immunoassay array human discoverymap 175+ v1.0
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Multiplexed Immunoassay Array Human Discoverymap 175+ V1.0, supplied by Myriad RBM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/multiplexed+immunoassay+panel+discoverymap+v+3+3/pmc08953113-95-10-17
Average 90 stars, based on 1 article reviews
multiplexed immunoassay array human discoverymap 175+ v1.0 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
multiplexed multibead elisa (inflammatory panel  (Assay Designs Inc)
90
Assay Designs Inc multiplexed multibead elisa (inflammatory panel
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Multiplexed Multibead Elisa (Inflammatory Panel, supplied by Assay Designs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/multiplexed+multibead+elisa++inflammatory+panel/us09176149-565-9-13
Average 90 stars, based on 1 article reviews
multiplexed multibead elisa (inflammatory panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
human/cytokine/chemokine/growth factor panel a 48-plex premixed magnetic bead multiplex assay  (Merck KGaA)
90
Merck KGaA human/cytokine/chemokine/growth factor panel a 48-plex premixed magnetic bead multiplex assay
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Human/Cytokine/Chemokine/Growth Factor Panel A 48 Plex Premixed Magnetic Bead Multiplex Assay, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/human+cytokine+chemokine+growth+factor+panel+a+48+plex+premixed+magnetic+bead+multiplex+assay/pm35975552-298-5-15
Average 90 stars, based on 1 article reviews
human/cytokine/chemokine/growth factor panel a 48-plex premixed magnetic bead multiplex assay - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
multiplexed bead-based immunoassay panel  (AimPlex Biosciences Inc)
90
AimPlex Biosciences Inc multiplexed bead-based immunoassay panel
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Multiplexed Bead Based Immunoassay Panel, supplied by AimPlex Biosciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/multiplexed+bead+based+immunoassay+panel/pmc09222195-113-25-27
Average 90 stars, based on 1 article reviews
multiplexed bead-based immunoassay panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
human kidneymap v. 1.0 multiplex panel  (Myriad RBM)
90
Myriad RBM human kidneymap v. 1.0 multiplex panel
Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, <t>microbiota,</t> <t>cytokine,</t> and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, <t>ELISA</t> was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.
Human Kidneymap V. 1.0 Multiplex Panel, supplied by Myriad RBM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+panels/human+kidneymap+v++1+0+multiplex+panel/pm30392454-139-11-17
Average 90 stars, based on 1 article reviews
human kidneymap v. 1.0 multiplex panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, microbiota, cytokine, and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, ELISA was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.

Journal: ACS Chemical Neuroscience

Article Title: Interplay of Neuroinflammation and Gut Microbiota Dysbiosis in Alzheimer’s Disease Using Diffusion Kurtosis Imaging Biomarker in 3 × Tg-AD Mouse Models

doi: 10.1021/acschemneuro.5c00063

Figure Lengend Snippet: Comprehensive experimental design for assessing AD pathology in mice. The timeline illustrates the multistep workflow for analyzing behavioral, imaging, microbiota, cytokine, and neuroinflammatory changes in 6-MO and 12-MO WT and AD mice ( N = 5 per group). On day 1, cognitive performance was evaluated using the T-maze task to assess working memory. On day 2, MRI/DKI was conducted to analyze microstructural brain changes. On day 3, fecal samples were processed with NGS to evaluate gut microbiota composition and diversity. On day 4, ELISA was used to quantify systemic pro-inflammatory cytokines, including IL-1β, IL-6, TNFα, and IFN-γ. Meanwhile, the serum samples were quantified for SCFA levels to assess dysregulated gut metabolism. On day 5, IHC was performed to assess microglial (Iba1) and astrocytic (GFAP) activation in key brain regions such as the mPFC, HIPP, and STR. This comprehensive workflow integrates multiple methodologies to investigate age- and disease-specific changes in AD pathology.

Article Snippet: Cytokine levels (IL-1β, IL-6, IFN-γ, and TNFα) were quantified using a multiplex ELISA kit (MEK1016; Boster, Pleasanton, CA, USA).

Techniques: Imaging, Enzyme-linked Immunosorbent Assay, Activation Assay